EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extending differential gene expression testing to handle genome aneuploidy in cancer

Katsiaryna Davydzenka iD, Giulio Caravagna iD, Guido Sanguinetti iD

PLOS Computational Biology · 27.03.2026 · 22 (3) · e1014134

DOI: 10.1371/journal.pcbi.1014134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Computational Biology, online erschienen am 27.03.2026. Verfasst von Katsiaryna Davydzenka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Theoretical and Scientific Data Science Group, International School of Advanced Studies, Trieste, Italy. Hauptthemen laut MEDLINE: Aneuploidy, Neoplasms, Gene Expression Profiling. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, European Union - NextGenerationEU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genome aneuploidy, characterized by copy number variations (CNVs), profoundly alters gene expression in cancer through direct gene dosage effects and indirect compensatory regulatory mechanisms. However, existing differential gene expression (DGE) testing methods do not differentiate between these mechanisms, conflating all expression changes, limiting biological interpretability and obscuring key genes involved in tumor progression. To address this, we developed DeConveil, a computational framework that extends traditional DGE analysis by integrating CNV data. Using a generalized linear model with a negative binomial distribution, DeConveil models RNA-seq expression counts while accounting for copy number gene dosage effects. We proposed a more fine-grained gene decomposition into dosage-sensitive (DSGs), dosage-insensitive (DIGs), and dosage-compensated (DCGs), which explicitly de-couples changes due to CNVs and bona fide changes in transcriptional regulation. Analysis of TCGA datasets from aneuploid solid cancers resulted in notable reclassification of genes, refining and expanding upon the results from conventional methods. Functional enrichment analysis identified distinct biological roles for DSGs, DIGs, and DCGs in tumor progression, immune regulation, and cell adhesion. In a breast cancer case study, DeConveil’s CN-aware analysis facilitated the identification of both known and novel prognostic biomarkers, including lncRNAs, linking gene expression signatures to survival outcomes. Utilizing these biomarkers for each gene group significantly improved patient risk stratification, yielding more accurate predictions compared to conventional methods. These results highlight DeConveil’s ability to disentangle CNV-driven from regulatory transcriptional changes, enhancing gene classification and biomarker discovery. By improving transcriptomic analysis, DeConveil provides a powerful tool for cancer research, precision oncology, with potential applications in therapeutic target identification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AneuploidyNeoplasmsGene Expression ProfilingHumansDNA Copy Number VariationsGene Expression Regulation, NeoplasticComputational BiologyBreast NeoplasmsFemaleGene Dosage

Autor:innen und Institutionen

  • Theoretical and Scientific Data Science Group, International School of Advanced Studies, Trieste, Italy.
  • University Campus Bio-Medico of Rome, Rome, Italy.
  • Department of Mathematics, Informatics and Geosciences, University of Trieste, Trieste, Italy.
  • Area Science Park, Trieste, Italy.

ORCID-Profile: Katsiaryna Davydzenka, Giulio Caravagna, Guido Sanguinetti

Förderung

  • Italian Association for Cancer Research
  • European Union - NextGenerationEU

Zitieren

APA

Davydzenka, K., Caravagna, G., & Sanguinetti, G. (2026). Extending differential gene expression testing to handle genome aneuploidy in cancer. PLOS Computational Biology, 22(3), e1014134. https://doi.org/10.1371/journal.pcbi.1014134

Vancouver

Davydzenka K, Caravagna G, Sanguinetti G. Extending differential gene expression testing to handle genome aneuploidy in cancer. PLOS Computational Biology. 2026;22(3):e1014134. doi:10.1371/journal.pcbi.1014134

BibTeX
@article{Davydzenka2026,
  author = {Davydzenka, Katsiaryna and Caravagna, Giulio and Sanguinetti, Guido},
  title = {Extending differential gene expression testing to handle genome aneuploidy in cancer},
  journal = {PLOS Computational Biology},
  year = {2026},
  volume = {22},
  number = {3},
  pages = {e1014134},
  doi = {10.1371/journal.pcbi.1014134}
}
Kostenlos starten →